Browse Pet Safety Reports
1,329,678 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,329,678 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,329,678 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Sep 1, 2025 | Dog | Lhasa Apso | Trilostane | Cough | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Aggression; Urinary tract disorder NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Boxer (German Boxer) | Pyrantel Pamoate;Sarolaner | Lethargy (see also Central nervous system depression in Neurological); Excess... | Ongoing |
| Sep 1, 2025 | Dog | Retriever - Golden | Carprofen | Bone and joint disorder NOS; Joint swelling | Ongoing |
| Sep 1, 2025 | Dog | Retriever - Labrador | Lotilaner,Moxidectin,Praziquantel,Pyr... | Lack of efficacy (ectoparasite) - flea; Digestive tract disorder NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Pointing Dog - German Short... | Ilunocitinib | Pancreatitis NOS; Cough; Respiratory tract disorder NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Retriever - Labrador | Oclacitinib Maleate | Lack of efficacy (fungi) - NOS | Ongoing |
| Sep 1, 2025 | Dog | Shepherd (unspecified) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Sep 1, 2025 | Dog | Retriever - Labrador | Genta/Posacon/Mometa Eardrops | Lack of efficacy (fungi) - NOS | Ongoing |
| Sep 1, 2025 | Dog | Terrier (unspecified) | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea | Recovered/Normal |
| Sep 1, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Emesis (multiple) | Recovered/Normal |
| Sep 1, 2025 | Dog | Terrier - Bull - Staffordshire | Selamectin | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Sep 1, 2025 | Dog | Retriever - Golden | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Swollen eye; Jaw disorder | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Foaming at the mouth; Pain NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Crossbred Canine/dog | Afoxolaner | Seizure NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Dog (unknown) | Tiletamine Hcl, Zolazepam Hcl | Lack of efficacy - NOS; Death by euthanasia | Recovered/Normal; Euthanized |
| Sep 1, 2025 | Dog | Boxer (German Boxer) | Ilunocitinib | Lymphoma; Enlarged lymph nodes (generalised) | Outcome Unknown |
| Sep 1, 2025 | Dog | Bulldog - English | Afoxolaner | Vomiting; Diarrhoea | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS; Leucocytosis NOS; Neutrophilia; Diarrhoea; Ketosis; A... | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Anxiety; Hyperactivity; Self trauma | Outcome Unknown |
| Sep 1, 2025 | Dog | Crossbred Canine/dog | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Sep 1, 2025 | Dog | Bichon Frise | Spinosad; Milbemycin Oxime | Vomiting | Outcome Unknown |
| Sep 1, 2025 | Dog | Chihuahua | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Sep 1, 2025 | Dog | Deutsche Dogge, Great Dane | Fluralaner 13.64% 12-Week Chew | Lethargy (see also Central nervous system depression in Neurological); Diarrh... | Recovered/Normal |
| Sep 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; Lack of efficacy - NOS; Weight loss; Heart murmur; Ketosis; Elevat... | Ongoing |
| Sep 1, 2025 | Dog | Siberian Husky | Selamectin | Increased seizure frequency | Outcome Unknown |
| Sep 1, 2025 | Horse | Rocky Mountain Horse | Pergolide Mesylate | Twitching; Behavioural disorder NOS; Seizure NOS; Increased sweating; Halluci... | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Mediumhair | Bexagliflozin | Hypercalcaemia | Ongoing |
| Sep 1, 2025 | Dog | Terrier - Yorkshire | Pyrantel Pamoate;Sarolaner | Tremor; Seizure NOS; Stiffness NOS; Unable to walk; Dazed; Lack of response t... | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (unknown) | Trilostane | Accidental exposure; Not himself/herself; Off colour; Behavioural disorder NO... | Outcome Unknown |
| Sep 1, 2025 | Dog | Chihuahua, Dog (unknown) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Vomiting | Recovered/Normal |
| Sep 1, 2025 | Dog | Dog (unknown) | Ivermectin; Pyrantel As Pamoate Salt | Unexplained death | Died |
| Sep 1, 2025 | Dog | Coonhound (unspecified) | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (other) | Frunevetmab | Dermatitis | Recovered/Normal |
| Sep 1, 2025 | Dog | Akita, Dog (unknown) | Ilunocitinib | Behavioural disorder NOS; Lethargy (see also Central nervous system depressio... | Outcome Unknown |
| Sep 1, 2025 | Dog | Shar Pei, Dog (unknown) | Bedinvetmab | Deafness; Limb weakness; Localised itching; Underdose | Ongoing |
| Sep 1, 2025 | Dog | Portuguese Water Dog | Oclacitinib Maleate | Lack of efficacy - NOS | Outcome Unknown |
| Sep 1, 2025 | Dog | Dog (unknown) | Spinosad | Lack of efficacy (ectoparasite) - flea; Emesis | Ongoing |
| Sep 1, 2025 | Dog | Shepherd Dog - German | Grapiprant | Anxiety; Inappropriate urination; Polydipsia; Mucous stool; Vomiting; Panting | Recovered/Normal |
| Sep 1, 2025 | Dog | Shih Tzu, Dog (other) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Diarrhoea; Behavioural disorder NOS | Recovered/Normal |
| Sep 1, 2025 | Dog | Retriever - Labrador, Dog (... | Lotilaner,Moxidectin,Praziquantel,Pyr... | Hepatitis; Elevated alanine aminotransferase (ALT) | Ongoing |
| Sep 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Pale mucous membrane; Neurological disorder NOS | Recovered/Normal |
| Sep 1, 2025 | Dog | Terrier - Yorkshire | Ilunocitinib | Partial lack of efficacy; Alopecia; Erythema (for urticaria see Immune SOC); ... | Ongoing |
| Sep 1, 2025 | Dog | Collie - Border, Dog (unknown) | Bedinvetmab | Seizure NOS; Shaking; Inappropriate elimination NOS; Nystagmus; Leucopenia NO... | Ongoing |
| Sep 1, 2025 | Dog | Terrier (unspecified), Dog ... | Milbemycin Oxime; Praziquantel | Unclassifiable adverse event | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Lack of efficacy - NOS; Lethargy (see also Central nervous system depression ... | Ongoing |
| Sep 1, 2025 | Dog | Newfoundland | Ilunocitinib | Neutropenia; Leucopenia NOS | Ongoing |
| Sep 1, 2025 | Dog | Shepherd Dog - Australian | Bedinvetmab | Arthritis; Gait abnormality; Abnormal posture; Partial lack of efficacy; Abno... | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Mirtazapine | Ocular discharge; Application site crust | Outcome Unknown |
| Sep 1, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Seizure NOS; Medication error NOS; Drug dose omission | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.